Biosimilar erythropoiesis‐stimulating agents are an effective and safe option for the management of myelofibrosis‐related anemia
暂无分享,去创建一个
V. Martinelli | L. Antolini | C. Gambacorti-Passerini | N. Pugliese | Laura Montelisciani | E. Elli | E. Crisà | G. Lanzarone | A. Castelli | E. Inzoli | I. Civettini | Elena Inzoli